UNSPSC 51101912: Hydroxychloroquine

This classification denotes an antimalarial agent with the molecular formula C18H26ClN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4QWG6N8QKH, chemically known as ethanol, 2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)- but generally known as hydroxychloroquine, which bears US NIH Compound Identifier 3652. European Medicines Agency schedules Hydroxychloroquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08077MIG.

UNSPSC 51101912 Hydroxychloroquine is a Commodity code that represents a single pharmaceutical product line, yet the recent state and local opportunities posted under this code show little alignment with hydroxychloroquine procurement itself. Instead, the tagged opportunities reflect broader pharmaceutical and medical supply sourcing — including antibiotic tablets, naloxone, and drug deactivation systems — suggesting the code may capture generic pharmaceutical inventory management and emergency preparedness contracting rather than hydroxychloroquine specifically. State and local health departments and county public health agencies are the primary issuing bodies under this code, procuring through cooperative purchasing consortia, piggyback contracts, and competitive bids to stock medications and medical supplies for emergency response and community health initiatives.

Recent activity spans Florida and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 (Solicitation 26482DPHPREPDB53392) for antibiotic tablets under a 12-month initial term with two renewal options. Seminole County, Florida issued an IFB (No. IFB60459723LAS) posted June 30, 2026 with a July 26, 2023 response deadline for 1,900 units of naloxone and 800 drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building and potential FEMA funding. The mismatch between the code's nominal scope (hydroxychloroquine) and the actual opportunities posted suggests this code may not be the primary vehicle for hydroxychloroquine procurement in state and local markets, or the recent opportunities are miscategorized.